Article
Integrated CRISPR-Cas9 and 3D Bioprinting Approach for Development and Evaluation of High-Throughput Advanced Organotypic Cancer Models
2026-02-05
Abstract excerpt
The integration of 3D bioprinting technology and CRISPR-Cas9 genome editing has become a game-changing method for creating complex organotypic cancer models. This integrated platform overcomes the drawbacks of traditional 2D culture systems by enabling precise genetic modifications within physiologically relevant, biomimetic tumor microenvironments. Researchers can more precisely recreate tumor progression, oncoge...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4fd35d70-f934-5bca-a6cc-a5d41bffe6f9
- DOI
- 10.20944/preprints202602.0262.v1
